Unassociated Document
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM
8-KA
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF
1934
Date
of Report (Date of earliest event reported)
April
25, 2007
Bovie
Medical Corporation
(Exact
name of registrant as specified in its
charter)
|
Delaware
|
1-31885
|
11-2644611
|
|
(State
or other jurisdiction
|
(Commission
|
(IRS
Employer
|
|
Of
incorporation)
|
File
Number)
|
Identification
No.)
|
|
734
Walt Whitman Road, Melville, New York
|
11747
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Registrant's
telephone number, including area code
(631)
421-5452
N/A
(Former
name or former address, if changed since last report.)
Check
the appropriate box below if the Form 8-K filing is intended
to
simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
o
Written communications
pursuant to Rule 425 under the Securities Act 17 CFR
230.425)
o
Soliciting material pursuant to Rule
l4a-12 under the Exchange Act (17
CFR 240.l4a-12)
o
Pre-commencement communications pursuant
to Rule l4d- 2(b) under the Exchange Act (17 CFR 240. l4d-
2(b)
o
Pre-commencement communications pursuant
to Rule 13 e-4( c) under the Exchange Act (17 CFR 240.13 e-4(
c)
ITEM:
4.01 CHANGES
IN REGISTRANT’S CERTIFYING ACCOUNTANT
On
April
25, 2007, Bovie Medical Corporation engaged the Certified Public Accounting
firm
of Kingery and Crouse PA, located at 2801 West Busch Boulevard, Suite 200,
Tampa, Florida 33618, as its independent auditor for fiscal 2007. The
appointment will be subject to approval of shareholders at our next annual
shareholder meeting. Such firm will review our quarterly filings with the SEC
during fiscal 2007.
On
January 12, 2007, Steven Bloom, the principal of Bloom and Company, LLP our
auditor since 1983, passed away suddenly and unexpectedly. Steven Bloom was
uniquely and highly respected by his peers as well as our management and staff
for his focused zeal for his work and his hands-on commitment to satisfying
each
and every aspect of the auditing process. His untimely passing occasioned our
management to re-evaluate its auditor situation which gave rise to the change
of
auditors. Given the fact that our manufacturing facilities are in Florida,
we
determined that logistically it would be more advantageous and efficient for
us
to have our auditor located in proximity to our operations in
Florida.
Bloom
& Company, LLP’s reports on our financial statements for either of the past
two fiscal years did not contain (a) an adverse opinion or disclaimer of
opinion, (b) qualification or modification as to audit scope or audit
principles. During our two most recent fiscal years and any subsequent interim
period before that date we had no disagreement with Bloom & Company LLP on
any matter of accounting principles or practices, financial statement disclosure
or auditing scope or procedure. Any such disagreements, if not resolved to
the
satisfaction of our former auditor, (Bloom & Company, LLP) would have caused
it to make reference to the subject matter of the disagreement in its
report.
Our
new
independent accountant was not consulted by us for any matter or any reason
whatsoever during the past two fiscal years or for any subsequent interim
period.
Bovie
Medical Corporation
By:
/S/
Andrew Makrides
Andrew
Makrides, President